Cargando…

Comparison of Apixaban and Low Molecular Weight Heparin in Preventing Deep Venous Thrombosis after Total Knee Arthroplasty in Older Adults

PURPOSE: To compare the effect of apixaban and low molecular weight heparin (LMWH) in the prevention and treatment of deep venous thrombosis (DVT) after total knee arthroplasty in older adult patients. MATERIALS AND METHODS: A total of 220 patients (average age of 67.8±6.4 years) undergoing total kn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Hui, Meng, Jia, Guo, Ting, Zhao, Jian-ning, Wang, Yi-cun, Wang, Jun, Qiu, Yang, Ding, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597473/ https://www.ncbi.nlm.nih.gov/pubmed/31250576 http://dx.doi.org/10.3349/ymj.2019.60.7.626

Ejemplares similares

Development of New Deep Venous Thrombosis While on Apixaban
por: Sharma, Munish, et al.
Publicado: (2017)

Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty
por: Lee, Joon Kyu, et al.
Publicado: (2021)

Spontaneous Heparin-Induced Thrombocytopenia and Venous Thromboembolism following Total Knee Arthroplasty
por: Baker, Kevin, et al.
Publicado: (2017)

EFFECTIVENESS OF DEEP VENOUS THROMBOSIS PREVENTION IN TOTAL HIP ARTHROPLASTY
por: MANFREDI, VICTOR MARTINS, et al.
Publicado: (2021)

Incidences of Deep Vein Thrombosis and Pulmonary Embolism after Total Knee Arthroplasty Using a Mechanical Compression Device with and without Low-Molecular-Weight Heparin
por: Park, Sin Hyung, et al.
Publicado: (2016)

No difference in the incidence or location of deep venous thrombosis according to use of pharmacological prophylaxis following total knee arthroplasty
por: Itou, Junya, et al.
Publicado: (2021)

Low Molecular Weight Heparin: A Practical Approach in Deep Venous Thrombosis in Palliative Care
por: Dutta, Samrat, et al.
Publicado: (2011)

Long-term Anticoagulation with Apixaban in Patients with Cerebral Venous Thrombosis
por: Bharath, Suman Preet, et al.
Publicado: (2023)

Enhanced pre-operative thrombolytic status is associated with the incidence of deep venous thrombosis in patients undergoing total knee arthroplasty
por: Tamura, Yukinori, et al.
Publicado: (2014)

A prediction nomogram for deep venous thrombosis risk in patients undergoing primary total hip and knee arthroplasty: a retrospective study
por: Lin, Zhencan, et al.
Publicado: (2023)

The efficacy and safety of low-molecular-weight heparin and unfractionated heparin in the treatment of cerebral venous sinus thrombosis
por: Afshari, Daryoush, et al.
Publicado: (2015)

Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences
por: Lanitis, Tereza, et al.
Publicado: (2017)

Patient compliance with deep vein thrombosis prophylaxis after total hip and total knee arthroplasty
por: Wiznia, Daniel H., et al.
Publicado: (2019)

Thrombin antithrombin complex concentration as an early predictor of deep vein thrombosis after total hip arthroplasty and total knee arthroplasty
por: Lin, Zhencan, et al.
Publicado: (2022)

Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) Trial
por: Liu, Xianchen, et al.
Publicado: (2015)

Venous Thromboembolism in Total Hip and Total Knee Arthroplasty
por: Simon, Samantha J., et al.
Publicado: (2023)

The Role of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia
por: Khalid, Sidra, et al.
Publicado: (2017)

Feasibility of anticoagulation using low molecular-weight heparin during catheter-directed thrombolysis for lower extremity deep venous thrombosis
por: Li, Yonghui, et al.
Publicado: (2021)

Clinical Efficacy of Conventional Heparin Anticoagulation Combined with Apixaban in the Treatment of Patients with Cerebral Venous Thrombosis and Its Effect on Serum D-Dimer and FIB Expression
por: Dong, Xiaohui, et al.
Publicado: (2021)

Effects of Natural Hirudin and Low Molecular Weight Heparin in Preventing Deep Venous Thrombosis in Aged Patients with Intertrochanteric Fracture
por: Zhang, Zhengdong, et al.
Publicado: (2018)

The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials
por: Meng, Jiahao, et al.
Publicado: (2023)

Safety and Feasibility of Subcutaneous Low Molecular Weight Heparin for Cerebral Venous Sinus Thrombosis
por: Kim, Ji Seon, et al.
Publicado: (2005)

Analysis of Risk Factors for Lower-limb Deep Venous Thrombosis in Old Patients after Knee Arthroplasty
por: Kang, Jian, et al.
Publicado: (2015)

Apixaban/heparin/warfarin: Treatment failure: case report
Publicado: (2021)

The influence of tourniquet use and operative time on the incidence of deep vein thrombosis in total knee arthroplasty
por: Hernandez, Arnaldo José, et al.
Publicado: (2012)

Inflammatory Biomarkers as Prognostic Factors of Acute Deep Vein Thrombosis Following the Total Knee Arthroplasty
por: Melinte, Răzvan Marian, et al.
Publicado: (2022)

Robotic-assisted total knee arthroplasty is not associated with increased risk of postoperative deep vein thrombosis
por: Itou, Junya, et al.
Publicado: (2023)

Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
por: Çiçek, Necati, et al.
Publicado: (2021)

Predictive value of preoperative erythrocyte electrophoresis exponent for acute deep vein thrombosis after total knee arthroplasty in patients with knee osteoarthritis
por: Xiaoyu, Dai, et al.
Publicado: (2020)

Low molecular weight heparin versus unfractionated heparin in the management of cerebral venous thrombosis: A systematic review and meta-analysis
por: Qureshi, Anjum, et al.
Publicado: (2017)

Risk‐Stratified Venous Thromboembolism Prophylaxis after Total Joint Arthroplasty: Low Molecular Weight Heparins and Sequential Aspirin vs Aggressive Chemoprophylaxis
por: Peng, Hui‐ming, et al.
Publicado: (2021)

Efficacy of Low Molecular Weight Heparin in Preventing Perinatal Venous Thrombosis: A Meta-Analysis
por: Huang, Yan, et al.
Publicado: (2022)

Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A U.S. Claims Data Analysis
por: Cohen, Alexander, et al.
Publicado: (2021)

A Cohort Study of Rivaroxaban Combined with D-Dimer Dynamic Monitoring in the Prevention of Deep Venous Thrombosis after Knee Arthroplasty
por: Dong, Yongyong, et al.
Publicado: (2022)

Total Knee Arthroplasty in a Diagnosed Case of Deep Vein Thrombosis - Our Experience and Review of Literature
por: Agarwal, Saurabh, et al.
Publicado: (2017)

Superficial femoral artery pseudoaneurysm, compartment syndrome, and deep vein thrombosis after total knee arthroplasty
por: Sánchez, Carlos A., et al.
Publicado: (2020)

Efficacy and risks of fondaparinux 7.5 mg for deep vein thrombosis after total knee arthroplasty
por: Nojiri, Sho, et al.
Publicado: (2019)

Comparison of the efficacy of low-molecular-weight heparin and fondaparinux sodium after total knee arthroplasty: a retrospective cohort study
por: Yang, Tianxiang, et al.
Publicado: (2023)

Short-duration chemoprophylaxis might reduce incidence of deep vein thrombosis in Asian patients undergoing total knee arthroplasty
por: Zhang, Siyuan, et al.
Publicado: (2020)

Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dgtik4msr1kqao5gniiu1kf4kt